十年后。一项针对46名患者体内121颗氧化(TiUnite™)诺贝尔种植体的前瞻性单中心临床研究结果。

Ten years later. Results from a prospective single-centre clinical study on 121 oxidized (TiUnite™) Brånemark implants in 46 patients.

作者信息

Östman Pär-Olov, Hellman Mats, Sennerby Lars

出版信息

Clin Implant Dent Relat Res. 2012 Dec;14(6):852-60. doi: 10.1111/j.1708-8208.2012.00453.x. Epub 2012 May 29.

Abstract

BACKGROUND

Concerns have been raised that use of surface-modified implants may result in peri-implant infection and marked marginal bone loss over time.

PURPOSE

The aim of this prospective study was to evaluate the survival rate, marginal bone, and soft tissue conditions at surface-modified titanium dental implants after 10 years of function.

MATERIAL AND METHODS

Forty-six totally and partially edentulous patients were provided with 121 Brånemark oxidized implants (TiUnite™, Nobel Biocare AB, Gothenburg, Sweden). Twenty-four (20%) implants were immediate loaded and 97 (80%) were placed using a two-stage procedure. A total of 22 single, 23 partial, and 7 total restorations were delivered. Clinical and radiographic checkups were carried out after 3, 6, 12 months, and thereafter annually up to 10 years. At these occasions, oral hygiene was evaluated and peri-implant mucosa examined by probing. If needed, patients were enrolled in an individual program for hygiene controls and professional cleaning. Marginal bone loss was evaluated in intraoral radiographs taken at baseline and after 1, 5, and 10 years of function.

RESULTS

One (0.8%) implant failed after 8 years giving a Survival Rate (SR) of 99.2% after 10 years. A total of 11 sites (9.2%) showed bleeding on probing (BP) at the 10th annual checkup. The mean marginal bone loss was 0.7 ± 1.35 mm based on 106 readable pairs of radiographs from baseline and from the 10th annual examination. Twelve (11.3%) implants showed more than 2 mm bone loss, and five (4.7%) showed more than 3 mm of bone loss after 10 years. For the latter, all patients were smokers and had poor or acceptable oral hygiene. All five implants with >3 mm bone loss showed BP and two (1.9%) showed suppuration from the pocket. For the remaining seven implants with more than 2 mm bone loss, no correlation to smoking, oral hygiene, bleeding, or pus could be seen. Time/marginal bone level plots of the 12 implants with more than 2 mm bone loss after 10 years, showed minor changes from the first annual checkup except for the two infected implants.

CONCLUSIONS

It is concluded that good long-term clinical outcomes can be obtained with oxidized titanium dental implants. Only 1.9% of examined implants showed significant marginal bone loss together with bleeding and suppuration after 10 years of function.

摘要

背景

有人担心使用表面改性种植体可能会随着时间的推移导致种植体周围感染和明显的边缘骨丢失。

目的

这项前瞻性研究的目的是评估表面改性钛牙种植体在功能使用10年后的生存率、边缘骨和软组织状况。

材料与方法

46例全口或部分牙列缺失患者植入了121枚Brånemark氧化种植体(TiUnite™,诺贝尔生物保健公司,瑞典哥德堡)。24枚(20%)种植体即刻加载,97枚(80%)采用两阶段手术植入。共交付了22枚单颗修复体、23枚局部修复体和7枚全口修复体。在3个月、6个月、12个月后进行临床和影像学检查,此后每年检查一次,直至10年。在这些检查时,评估口腔卫生状况,并通过探诊检查种植体周围黏膜。如有需要,患者参加个人卫生控制和专业清洁计划。在基线以及功能使用1年、5年和10年后拍摄的口腔X光片中评估边缘骨丢失情况。

结果

1枚(0.8%)种植体在8年后失败,10年后的生存率(SR)为99.2%。在第10次年度检查时,共有11个部位(9.2%)探诊出血(BP)。根据106对从基线和第10次年度检查获得的可读X光片,平均边缘骨丢失为0.7±1.35毫米。12枚(11.3%)种植体在10年后显示骨丢失超过2毫米,5枚(4.7%)显示骨丢失超过3毫米。对于后者,所有患者均为吸烟者,口腔卫生状况差或尚可。所有5枚骨丢失>3毫米的种植体均显示探诊出血,2枚(1.9%)显示袋内有脓性分泌物。对于其余7枚骨丢失超过2毫米的种植体,则未发现与吸烟、口腔卫生、出血或脓性分泌物有关。对10年后骨丢失超过2毫米的12枚种植体的时间/边缘骨水平图进行分析,结果显示,除了2枚感染种植体外,从第一次年度检查以来变化较小。

结论

得出的结论是,氧化钛牙种植体可获得良好的长期临床效果。在功能使用10年后,仅1.9%的检查种植体显示出明显的边缘骨丢失并伴有出血和脓性分泌物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索